Home/Filings/4/0001636178-25-000009
4//SEC Filing

EDGEMOND JAMES 4

Accession 0001636178-25-000009

CIK 0001082554other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 4:54 PM ET

Size

31.0 KB

Accession

0001636178-25-000009

Insider Transaction Report

Form 4
Period: 2025-12-08
EDGEMOND JAMES
CFO AND TREASURER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-08$146.03/sh+21,000$3,066,63029,142 total
  • Sale

    Common Stock

    2025-12-08$475.08/sh400$190,03428,742 total
  • Sale

    Common Stock

    2025-12-08$476.17/sh2,957$1,408,04625,785 total
  • Sale

    Common Stock

    2025-12-08$477.18/sh6,529$3,115,50219,256 total
  • Sale

    Common Stock

    2025-12-08$477.97/sh3,295$1,574,90715,961 total
  • Sale

    Common Stock

    2025-12-08$479.16/sh3,139$1,504,07412,822 total
  • Sale

    Common Stock

    2025-12-08$480.03/sh1,559$748,36911,263 total
  • Sale

    Common Stock

    2025-12-08$481.22/sh477$229,54410,786 total
  • Sale

    Common Stock

    2025-12-08$482.22/sh523$252,19910,263 total
  • Sale

    Common Stock

    2025-12-08$483.29/sh742$358,5999,521 total
  • Sale

    Common Stock

    2025-12-08$484.51/sh739$358,0538,782 total
  • Sale

    Common Stock

    2025-12-08$484.85/sh120$58,1828,662 total
  • Sale

    Common Stock

    2025-12-08$486.71/sh520$253,0908,142 total
  • Exercise/Conversion

    Stock Option

    2025-12-0821,0003,517 total
    Exercise: $146.03From: 2020-03-15Exp: 2027-03-15Common Stock (21,000 underlying)
Footnotes (13)
  • [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025.
  • [F10]This transaction was executed in multiple trades at prices ranging from $482.76 to $483.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F11]This transaction was executed in multiple trades at prices ranging from $483.76 to $484.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F12]This transaction was executed in multiple trades at prices ranging from $484.83 to $484.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F13]This transaction was executed in multiple trades at prices ranging from $486.68 to $486.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $474.57 to $475.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $475.60 to $476.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $476.60 to $477.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $477.60 to $478.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $478.63 to $479.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F7]This transaction was executed in multiple trades at prices ranging from $479.65 to $480.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F8]This transaction was executed in multiple trades at prices ranging from $480.68 to $481.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F9]This transaction was executed in multiple trades at prices ranging from $481.70 to $482.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

UNITED THERAPEUTICS Corp

CIK 0001082554

Entity typeother

Related Parties

1
  • filerCIK 0001636178

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:54 PM ET
Size
31.0 KB